We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
(-4.8%)
Cap. Flow
+$505M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$83.5M |
| 2 |
S&P Global
SPGI
|
+$73.5M |
| 3 |
Tesla
TSLA
|
+$55.8M |
| 4 |
Microsoft
MSFT
|
+$45.9M |
| 5 |
Amazon
AMZN
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$88.8M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$74.7M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$31.7M |
| 4 |
Abbott
ABT
|
+$25.5M |
| 5 |
Exelon
EXC
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.74% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SURF
2851
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $122K | ﹤0.01% |
41,388
-4,055
| -9% | -$14.2K |
|
2852
Aurora
AUR
$13.8B
| $121K | ﹤0.01% |
+21,648
| New | +$125K |
|
|
SQZ
2853
DELISTED
SQZ Biotechnologies Company
SQZ
| $121K | ﹤0.01% |
25,148
-1,335
| -5% | -$8.48K |
|
2854
Quince Therapeutics
QNCX
$29.5M
| $120K | ﹤0.01% |
97
+1
| +1% | +$1.36K |
|
2855
1stdibs.com
DIBS
$171M
| $119K | ﹤0.01% |
+14,868
| New | +$143K |
|
2856
TherapeuticsMD
TXMD
$24M
| $119K | ﹤0.01% |
6,251
+288
| +5% | +$4.53K |
|
2857
Remitly
RELY
$5.14B
| $118K | ﹤0.01% |
+12,005
| New | +$143K |
|
|
RENT
2858
Rent the Runway
RENT
$124M
| $117K | ﹤0.01% |
852
+281
| +49% | +$33K |
|
|
NAGE
2859
Niagen Bioscience
NAGE
$247M
| $116K | ﹤0.01% |
47,049
+640
| +1% | +$1.75K |
|
2860
Cardiff Oncology
CRDF
$77.2M
| $115K | ﹤0.01% |
46,290
-294
| -0.6% | -$1.04K |
|
|
MTEM
2861
DELISTED
Molecular Templates, Inc.
MTEM
| $115K | ﹤0.01% |
2,213
+76
| +4% | +$3.36K |
|
2862
Mitsubishi UFJ Financial
MUFG
$254B
| $114K | ﹤0.01% |
18,442
+85
| +0.5% | +$528 |
|
|
ATHX
2863
DELISTED
Athersys, Inc. Common Stock
ATHX
| $114K | ﹤0.01% |
7,558
-10
| -0.1% | -$209 |
|
|
MILE
2864
DELISTED
Metromile, Inc. Common Stock
MILE
| $114K | ﹤0.01% |
86,359
+6,139
| +8% | +$8.89K |
|
2865
Aveanna Healthcare
AVAH
$2.07B
| $113K | ﹤0.01% |
32,997
+2,462
| +8% | +$13.4K |
|
|
TBHC
2866
DELISTED
The Brand House Collective
TBHC
| $113K | ﹤0.01% |
12,205
+461
| +4% | +$6.57K |
|
2867
Spyre Therapeutics
SYRE
$9.25B
| $113K | ﹤0.01% |
1,957
-200
| -9% | -$16.8K |
|
|
DS
2868
DELISTED
Drive Shack Inc.
DS
| $113K | ﹤0.01% |
73,645
+2,097
| +3% | +$2.85K |
|
2869
Puma Biotechnology
PBYI
$454M
| $112K | ﹤0.01% |
38,775
+4
| +0% | +$10 |
|
2870
Shattuck Labs
STTK
$694M
| $112K | ﹤0.01% |
26,270
+2,310
| +10% | +$13.1K |
|
2871
Annexon
ANNX
$886M
| $106K | ﹤0.01% |
38,917
+1,142
| +3% | +$7.03K |
|
|
ITI
2872
DELISTED
Iteris, Inc.
ITI
| $106K | ﹤0.01% |
35,455
-116
| -0.3% | -$402 |
|
2873
AquaBounty Technologies
AQB
$6.02M
| $105K | ﹤0.01% |
2,807
+78
| +3% | +$2.71K |
|
2874
Ardelyx
ARDX
$997M
| $105K | ﹤0.01% |
97,981
+2,816
| +3% | +$2.52K |
|
|
EEX
2875
DELISTED
Emerald Holding
EEX
| $104K | ﹤0.01% |
30,725
-4,369
| -12% | -$15.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
- RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
- RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
- RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
- RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
- RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.